Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

10.47 +0.25 (+2.50%)
Streaming Delayed Price Updated: 1:56 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
5 Insightful Analyst Questions From Fortrea’s Q3 Earnings Call
Fortrea’s third quarter results were met with a significant positive response from the market, as robust demand across its clinical pharmacology and clinical development businesses drove revenue... 
Via StockStory
Topics Earnings World Trade
News headline image
Q3 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Fortrea (NASDAQ:FTRE) and the... 
Via StockStory
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
Where Fortrea Holdings Stands With Analysts ↗
 
Via Benzinga
News headline image
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
FTRE Q3 Deep Dive: Revenue Outpaces Estimates, Margin Expansion Remains a Focus
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 3.9% year on year to $701.3 million. The company’s... 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 25.3% in the morning session after the company reported third-quarter financial results that showed stronger-than-expected... 
Via StockStory
Topics Artificial Intelligence Earnings Initial Public Offering
News headline image
When Bad News is Good News: Fortrea and Flowco Defy Earnings Logic
In a financial landscape often dictated by strict adherence to earnings forecasts, recent market movements have showcased a fascinating deviation from traditional expectations. Public companies like... 
Via MarketMinute
Topics Earnings Economy Energy
News headline image
FORTREA HOLDINGS INC (NASDAQ:FTRE) Reports Q3 2025 Revenue Beat and Adjusted EPS Miss ↗
Fortrea posts Q3 2025 results with a revenue beat but an adjusted EPS miss. The CRO raises its full-year revenue guidance and reports a strong book-to-bill ratio of 1.13x. 
Via Chartmill
News headline image
Fortrea (NASDAQ:FTRE) Beats Q3 Sales Expectations
Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q3 CY2025, with sales up 3.9% year on year to $701.3 million. The company’s full-year revenue guidance... 
Via StockStory
News headline image
Fortrea (FTRE) Reports Q3: Everything You Need To Know Ahead Of Earnings
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be announcing earnings results this Wednesday morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Inflated Stocks We Find Risky
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
3 Unprofitable Stocks We Steer Clear Of
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
3 Cash-Burning Stocks with Questionable Fundamentals
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 7.7% in the afternoon session after it commenced a cash tender offer to buy back up to $75.74 million of its outstanding senior... 
Via StockStory
Topics Economy Government Initial Public Offering
News headline image
3 Unpopular Stocks That Concern Us
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
3 Volatile Stocks Walking a Fine Line
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
Why Fortrea (FTRE) Stock Is Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.1% in the afternoon session after Evercore ISI Group raised its price target on the company to $11.00 from a previous $7.00. 
Via StockStory
Topics Artificial Intelligence Initial Public Offering World Trade
News headline image
Why Fortrea (FTRE) Shares Are Sliding Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 6.3% in the afternoon session after negative news weighed on the broader healthcare sector, including a new U.S. government... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering World Trade
News headline image
3 Small-Cap Stocks We Find Risky
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.5% in the afternoon session after Baird raised its price target on the stock to $14.00. This positive analyst action adds to... 
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Demystifying Fortrea Holdings: Insights From 6 Analyst Reviews ↗
 
Via Benzinga
News headline image
3 Stocks Under $10 We Find Risky
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
News headline image
Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Topics Economy
News headline image
Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
News headline image
Reflecting On Drug Development Inputs & Services Stocks’ Q2 Earnings: Fortrea (NASDAQ:FTRE)
Looking back on drug development inputs & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Fortrea (NASDAQ:FTRE) and its peers. 
Via StockStory
News headline image
LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S.... 
Via StockStory
Topics Economy Stocks
News headline image
3 Cash-Burning Stocks We’re Skeptical Of
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.